JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2019, 68(4):157-160 | DOI: 10.36290/csf.2019.018

Theory and practice of pharmacopoeial control of quality of drugs and excipients X. Number of parallel determinations, processing of results and their use in the assessment of the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.)

Jan Šubert, Jozef Kolář1,*
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav aplikované farmacie, Brno

In the European Pharmacopoeia (Ph. Eur.) there is no prescribed number of parallel determinations of the content of active substances and excipients. The authors suggest adding at least three determinations. The results of parallel determinations suggest to test for outliers before using test based on the ratio of the range of results (p = 0.95) and not to compare individual results with the tolerance limits given in Ph. Eur., but with their arithmetic mean. Furthermore, they propose to extend the Chapter 5.3. of the European Pharmacopoeia so as to be applicable not only to bioassays, but also to chemical, physicochemical and physical assays and tests, starting with the content of active substances and excipients.

Keywords: Ph. Eur.; extension of the chapter 5.3.; determination of content; number of determinations; outliers testing; use of results

Received: July 12, 2019; Accepted: August 8, 2019; Published: April 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šubert J, Kolář J. Theory and practice of pharmacopoeial control of quality of drugs and excipients X. Number of parallel determinations, processing of results and their use in the assessment of the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.). Čes. slov. farm. 2019;68(4):157-160. doi: 10.36290/csf.2019.018.
Download citation

References

  1. European Pharmacopoeia Online 9.5. http://online6.edqm.eu/ep905/ (5. 2. 2019).
  2. Arzneibuch der Deutschen Demokratischen Republik: AB-DDR 87. Berlin: Akademie-Verlag 1975-1987; s. 93. http://www.digibib.tu-bs.de/?docid=00000955 (24. 2. 2019).
  3. Compendium Medicamentorum (Sammlung vereinheitlichter Forderungen und Prüfmethoden für Arzneimittel), I. Lieferung. Berlin: Akademie-Verlag 1970; I-11.0.01.
  4. Československý lékopis, 4. vydání, svazek I. Praha: Avicenum 1987; 53.
  5. Šubert J., Melichar B. Otázky standardního zpracování a interpretace výsledků chemických stanovení v lékopise. Českoslov. Farm. 1977; 26, 72-75.
  6. Daas A. G. J., Miller J. H. McB. Content limits in the European Pharmacopoeia (Part 1). Pharmeuropa 1997; 9, 148-156.
  7. Daas A. G. J., Miller J. H. McB. Content limits in the European Pharmacopoeia (Part 2). Pharmeuropa 1998; 10, 137-146.
  8. Ebel S. Assay content limits in the pharmacopoeia. Pharmeuropa 1997; 9, 143-147.
  9. van Rompay J. How to construct and use the specifications of chemical substances. Pharmeuropa 1997; 9, 135-139.
  10. van de Vaart F. J. Content limits - setting and use. Pharmeuropa 1997; 9, 140-143.
  11. Doerffel K., Eckschlager K. Optimální postup chemické analýzy. 2. vydání. Praha: SNTL 1988.
  12. Anonym. The fallacy of the best two out of three. NBS Technical News Bulletin 1949; 33, 77-78.
  13. Tietjen G. L., Beckman R. J. On duplicate measurements in the chemical laboratory. Technometrics 1975; 17, 53-56. Go to original source...
  14. Lieblein J. Properties of certain statistics involving the closest pair in a sample of three observations. J. Res. Natl. Bur. Stand. 1952; 48, 255-268. Go to original source...
  15. Youden W. J. Sets of three measurements. Sci. Mon. 1953; 77, 143-147.
  16. Blodgett R. J. Averaging the closest two out of three observations. J. AOAC Int. 2000; 83, 661-664. Go to original source...
  17. Eckschlager K., Horsák I., Kodejš Z. Vyhodnocování analytických výsledků a metod. Praha: SNTL 1980.
  18. Thompson M. Precision in chemical analysis: a critical survey of uses and abuses. Anal. Methods 2012; 4, 1598-1611. www.rsc.org/methods doi:10.1039/c2ay25083g (27. 5. 2019). Go to original source...
  19. Dixon W. J. Ratios involving extreme values. Ann. Math. Stat. 1951; 22, 68-78. Go to original source...
  20. Dean R. B., Dixon W. J. Simplified statistics for small numbers of observations. Anal. Chem. 1951; 23, 636-638. Go to original source...
  21. Grubbs F. E. Procedures for detecting outlying observations in samples. Technometrics 1969; 11, 1-21. Go to original source...
  22. Eckschlager K. Errors, measurement and results in chemical analysis. London: Van Nostrand Reinhold Company 1969.
  23. Československý lékopis, 4. vydání, svazek I. Praha: Avicenum 1987; 161-162.
  24. Státní ústav pro kontrolu léčiv v Praze. Závazná kontrolní metoda ZKM 149 Natrium sulfurosum crystallisatum. Met. Ves. SÚKL 1981; 29, 31-34.
  25. Šubert J., Kolář J. Teorie a praxe lékopisné kontroly jakosti léčiv a pomocných látek. IX. Problematika tolerančních mezí na obsah léčivých a pomocných látek v Evropském lékopisu (Ph. Eur.). Čes. slov. Farm. 2019; 68, 91-94. Go to original source...
  26. Gosudarstvennaja Farmakopeja Rossijskoj Federacii, XIV izd., Tom I. Moskva: Ministerstvo zdravoochranenija Rossijskoj federacii 2018. http://femb.ru/femb/pharmacopea.php (31. 7. 2019).
  27. The Japanese Pharmacopoeia, Seventeenth Edition (JP17) the Electronic version. http://jpdb.nihs.go.jp/jp17e/ (2. 8. 2019).
  28. Supplement I to the Japanese Pharmacopoeia Seventeenth Edition https://www.mhlw.go.jp/content/11120000/000352508.pdf (3. 8. 2019).




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.